UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Non-immunotherapy options for the first-line management of hepatocellular carcinoma: exploring the evolving role of sorafenib and lenvatinib in advanced disease

Current oncology (Toronto), 2020-11, Vol.27 (Suppl 3), p.S165-172

2020

Volltextzugriff (PDF)

Collaborations in Dietetics Education across Countries

Journal of the Academy of Nutrition and Dietetics, 2016-09, Vol.116 (9), p.A68-A68

2016

Volltextzugriff (PDF)

Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials

Current oncology (Toronto), 2018-06, Vol.25 (Suppl 1), p.S28-37

2018

Volltextzugriff (PDF)

Longitudinal health utilities, symptoms and toxicities in patients with ALK- rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment

Current oncology (Toronto), 2020-12, Vol.27 (6), p.e552-559

2020

Volltextzugriff (PDF)

A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-08, Vol.33 (8), p.527-535

2021

Volltextzugriff (PDF)

Molecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

Annals of oncology, 2018-10, Vol.29, p.viii240-viii241

2018

Volltextzugriff (PDF)

2511 TI-CE for relapsed germ cell tumours: A European BMT centre experience

European journal of cancer (1990), 2015-09, Vol.51, p.S477-S478

2015

Volltextzugriff (PDF)

Community Acquisition of Gentamicin-Sensitive Methicillin-Resistant Staphylococcus aureus in Southeast Queensland, Australia

Journal of Clinical Microbiology, 2000-11, Vol.38 (11), p.3926-3931

2000

Volltextzugriff (PDF)

Trial in Progress: Atezolizumab and Bevacizumab Pre-liver Transplantation for Patients with Hepatocellular Carcinoma beyond Milan Criteria

HPB (Oxford, England), 2023, Vol.25, p.S560-S561

2023

Volltextzugriff (PDF)

Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review

Clinical sarcoma research, 2015-07, Vol.5 (1), p.17-17, Article 17

2015

Volltextzugriff (PDF)

Non-Immunotherapy Options for the First-Line Management of Hepatocellular Carcinoma: Exploring the Evolving Role of Sorafenib and Lenvatinib in Advanced Disease

Current oncology (Toronto), 2020-11, Vol.27 (13), p.165

2020

Volltextzugriff (PDF)

P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S420-S420

2021

Volltextzugriff (PDF)

P1.13-15 Detection of EGFR Mutations in cfDNA and Development of Resistance

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S587-S587

2018

Volltextzugriff (PDF)

Cascade testing following universal immunohistochemistry for mismatch repair protiens

Annals of oncology, 2016-10, Vol.27, p.vi186-vi186

2016

Volltextzugriff (PDF)

PD-0423: Risk group classification for locoregional failure following upfront surgery for pancreatic cancer

Radiotherapy and oncology, 2020-11, Vol.152, p.S230-S231

2020

Volltextzugriff (PDF)

Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: a propensity score matched study

HPB (Oxford, England), 2024, Vol.26, p.S110-S111

2024

Volltextzugriff (PDF)

81P The influence of comorbidity on health utility score (HUS) and health-related quality of life (HRQoL) in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC)

Journal of thoracic oncology, 2018-04, Vol.13 (4), p.S44-S45

2018

Volltextzugriff (PDF)

P2.15-10 Determinants of Health Utility Scores (HUS) in Patients with ALK Rearranged Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S820-S821

2018

Volltextzugriff (PDF)

P86.08 Phase 2 Study of Zenocutuzumab (MCLA-128), a Bispecific HER2/HER3 Antibody in NRG1 Fusion-Positive Advanced Solid Tumors

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S675-S675

2021

Volltextzugriff (PDF)

Evidence for semantic learning in profound amnesia: An investigation with patient H.M

Hippocampus, 2004, Vol.14 (4), p.417-425

2004

Volltextzugriff (PDF)

P1.01-42 Real-World Evaluation of Tolerability in Older Adult Patients (≥75 years old) with EGFR-mutated NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S476-S477

2018

Volltextzugriff (PDF)

P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S586-S586

2018

Volltextzugriff (PDF)

MA18.09 Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S420-S421

2018

Volltextzugriff (PDF)

712PMolecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy

Irish medical journal, 2016-03, Vol.109 (3), p.375-375

2016

Volltextzugriff (PDF)

1 – 25 von 457

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(388)
Mit Volltextzugriff
(365)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(247)
Life Sciences & Biomedicine
(168)
Humans
(114)
Biological And Medical Sciences
(68)
Physical Sciences
(55)
Animals
(47)
Male
(47)
Medical Sciences
(47)
Female
(43)
Technology
(43)
General & Internal Medicine
(31)
Fundamental And Applied Biological Sciences. Psychology
(29)
Materials Science
(26)
Middle Aged
(24)
Aged
(22)
Chemistry
(21)
Medicine, General & Internal
(21)
Physics
(21)
Materials Science, Multidisciplinary
(19)
Mice
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Non-immunotherapy options for the first-line management of hepatocellular carcinoma: exploring the evolving role of sorafenib and lenvatinib in advanced disease

Collaborations in Dietetics Education across Countries

Resistance to epidermal growth factor receptor tyrosine kinase inhibitors, T790M, and clinical trials

Longitudinal health utilities, symptoms and toxicities in patients with ALK- rearranged lung cancer treated with tyrosine kinase inhibitors: a prospective real-world assessment

A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy

Molecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

2511 TI-CE for relapsed germ cell tumours: A European BMT centre experience

Community Acquisition of Gentamicin-Sensitive Methicillin-Resistant Staphylococcus aureus in Southeast Queensland, Australia

Trial in Progress: Atezolizumab and Bevacizumab Pre-liver Transplantation for Patients with Hepatocellular Carcinoma beyond Milan Criteria

Perioperative chemotherapy in the treatment of osteosarcoma: a 26-year single institution review

Non-Immunotherapy Options for the First-Line Management of Hepatocellular Carcinoma: Exploring the Evolving Role of Sorafenib and Lenvatinib in Advanced Disease

P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC

P1.13-15 Detection of EGFR Mutations in cfDNA and Development of Resistance

Cascade testing following universal immunohistochemistry for mismatch repair protiens

PD-0423: Risk group classification for locoregional failure following upfront surgery for pancreatic cancer

Comparing resection and stereotactic body radiation therapy for hepatocellular carcinoma with macrovascular invasion: a propensity score matched study

81P The influence of comorbidity on health utility score (HUS) and health-related quality of life (HRQoL) in small cell lung cancer (SCLC) compared to non-small cell lung cancer (NSCLC)

P2.15-10 Determinants of Health Utility Scores (HUS) in Patients with ALK Rearranged Non-Small Cell Lung Cancer

P86.08 Phase 2 Study of Zenocutuzumab (MCLA-128), a Bispecific HER2/HER3 Antibody in NRG1 Fusion-Positive Advanced Solid Tumors

Evidence for semantic learning in profound amnesia: An investigation with patient H.M

P1.01-42 Real-World Evaluation of Tolerability in Older Adult Patients (≥75 years old) with EGFR-mutated NSCLC

P1.13-11 PRO-CTCAE Toxicities in Advanced NSCLC Patients with EGFR Mutations: A Real World Assessment

MA18.09 Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC

712PMolecular profiling of PDAC and response to chemotherapy: An update from the COMPASS trial

Osteosarcoma in a Patient Receiving Long-Term TNF Inhibitor Therapy

Aktive Filter

Suchergebnisse filtern